Transcriptional Enhancers Induce Insertional Gene Deregulation Independently From the Vector Type and Design
Open Access
- 1 May 2009
- journal article
- research article
- Published by Elsevier BV in Molecular Therapy
- Vol. 17 (5), 851-856
- https://doi.org/10.1038/mt.2009.51
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Correction of Laminin-5 Deficiency in Human Epidermal Stem Cells by Transcriptionally Targeted Lentiviral VectorsMolecular Therapy, 2008
- Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1JCI Insight, 2008
- Retroviral integration and human gene therapyJCI Insight, 2007
- Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapyJCI Insight, 2007
- Gammaretrovirus-mediated correction of SCID-X1 is associated with skewed vector integration site distribution in vivoJCI Insight, 2007
- Vector integration is nonrandom and clustered and influences the fate of lymphopoiesis in SCID-X1 gene therapyJCI Insight, 2007
- Site-Specific Integration into the Human Genome: Ready for Clinical Application?Rejuvenation Research, 2006
- Genome-wide analysis of retroviral DNA integrationNature Reviews Microbiology, 2005
- Activation of the T-Cell OncogeneLMO2after Gene Therapy for X-Linked Severe Combined ImmunodeficiencyThe New England Journal of Medicine, 2004
- BLAT—The BLAST-Like Alignment ToolGenome Research, 2002